BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/22/2023 8:49:19 AM | Browse: 553 | Download: 1488
Publication Name World Journal of Clinical Cases
Manuscript ID 88186
Country Greece
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Letter to the Editor
Article Title Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure
Manuscript Source Invited Manuscript
All Author List Christos Kourek, Alexandros Briasoulis, Grigorios Giamouzis, John Skoularigis and Andrew Xanthopoulos
ORCID
Author(s) ORCID Number
Christos Kourek http://orcid.org/0000-0003-4348-2153
Alexandros Briasoulis http://orcid.org/0000-0002-5740-9670
Grigorios Giamouzis http://orcid.org/0000-0002-7406-5427
John Skoularigis http://orcid.org/0000-0001-7159-2478
Andrew Xanthopoulos http://orcid.org/0000-0002-9439-3946
Funding Agency and Grant Number
Corresponding Author Andrew Xanthopoulos, FACC, MD, PhD, Senior Postdoctoral Fellow, Department of Cardiology, University Hospital of Larissa, Mezourlo, Larissa 41110, Greece. andrewvxanth@gmail.com
Key Words Heart failure; Recombinant; Brain natriuretic peptide; Outcomes
Core Tip Lyophilized recombinant brain natriuretic peptide is an exogenous peptide synthesized by artificial recombination technology, with a similar structure and similar physiological effects with the endogenous natriuretic peptide secreted by the human body. A recent single center, randomized study examined its safety and efficacy in 102 chronic heart failure patients, showing promising results. Larger randomized controlled trials are urgently needed.
Publish Date 2023-12-22 08:49
Citation Kourek C, Briasoulis A, Giamouzis G, Skoularigis J, Xanthopoulos A. Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure. World J Clin Cases 2023; 11(36): 8603-8605
URL https://www.wjgnet.com/2307-8960/full/v11/i36/8603.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i36.8603
Full Article (PDF) WJCC-11-8603-with-cover.pdf
Full Article (Word) WJCC-11-8603.docx